Credit Rating - NORWAY OPPLAND BIOLOGICAL LIMITED

Credit Risk Update: ACCOUNTS DUE FLAG: NORWAY OPPLAND BIOLOGICAL LIMITED, CHASE BUSINESS CENTRE, 39-41 CHASE SIDE, LONDON, N14 5BP. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The company was incorporated on 4 June 2020. The accounts next due date is 4 March 2022. There are no mortgages. The above was based on public record information as at 15 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.

Registered Number:	12644440
Date Incorporated:	4 June 2020
Date Latest Accounts:	Unknown

Legal Form:	Private Limited Company
Previous Names:	None
Registered Number:	12644440
Annual Return:	Unknown
Registered Office:	CHASE BUSINESS CENTRE, 39-41 CHASE SIDE, LONDON, N14 5BP
SIC Code and Operations:	99999

Number of Mortgages	0
Satisfied Mortgages	0
Part Satisfied Mortgages	0
Unsatisfied Mortgages	0

CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):		NORWAY OPPLAND BIOLOGICAL LIMITED Click Here to view this information
Risk Assessment:
Credit Rating:
First Report Score: (0-10):
Financial Status Guide:		10  Very Strong 9   Strong 8 Very Good 7 Good 6 Above Average 5 Average 4 Below Average 3 Poor 2 Weak 1 Very Weak 0 Critical

Report Created On 25 September 2024

Copyright © 2024 First Report Ltd

Recent Searches

Reg No.	Reg Name	Status
14998454	NORWAY OPRUN INTERNATIONAL GROUP CO., LTD	Active
13612783	NORWAY ORPHEUS GROUP BIOTECHNOLOGY CO LTD	Active - Proposal to Strike off
12275654	NORWAY ORPHEUS GROUP BIOTECHNOLOGY CO., LTD.	Active
15418465	NORWAY OSLAND PLANT NUTRITION TECHNOLOGY LIMITED	Active
14694685	NORWAY OSLO CHEMICAL CO., LTD	Active - Proposal to Strike off